Jak2 is involved in c-Myc induction by Bcr-Abl

Oncogene

Volumn 21, Issue 47, 2002, Pages 7137-7146

  Xie, Shanhai ^a   Lin, Hui ^a   Sun, Tong ^a   Arlinghaus, Ralph B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bcr Abl oncoprotein; c Myc induction; Jak2 tyrosine kinase; Philadelphia chromosome leukemia

Indexed keywords

ADAPTOR PROTEIN; BCR ABL PROTEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GROWTH FACTOR; IMATINIB; INTERLEUKIN 3; JANUS KINASE; LIGAND; MYC PROTEIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RNA;

APOPTOSIS; ARTICLE; BLAST CELL CRISIS; CARBOXY TERMINAL SEQUENCE; CHRONIC MYELOID LEUKEMIA; CLONE; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH;

CARRIER PROTEINS; CELL LINE; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION; GENES, MYC; HUMANS; JANUS KINASE 2; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; LEUPEPTINS; MUTAGENESIS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TYRPHOSTINS; XENOPUS PROTEINS;

JANUS; MUS MUSCULUS;

EID: 0037126385     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205942     Document Type: Article

References (44)

1. Afar DEH, Goga A, McLaughlin J, Witte ON and Sawyers CL. (1994). Science, 264, 424-426.
2. Besancon F, Afti A, Gespach C, Cayre YE and Bourgeade M-F. (1998). Proc. Natl. Acad. Sci. USA, 95, 8081-8086.
3. Carlesso N, Frank DA and Griffin JD. (1995). J. Exp. Med., 183, 811-820.
4. Chai SK, Nichols GL and Rothman PB. (1997). J. Immunol., 159, 4720-4728.
5. Chaturvedi P, Sharma S and Reddy EP. (1997). Mol. Cell. Biol., 17, 3295-3304.
6. Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AI and Brodeur GM. (1991). Proc. Natl. Acad. Sci. USA, 88, 139-143.
7. Danial NN, Losman JA, Lu T, Yip N, Krishmnan K, Krolewski J, Goff SP, Wang JYJ and Rothman PB. (1998). Mol. Cell. Biol., 18, 6795-6804.
8. de Groot RP, Raaijmakers JAM, Lammers JWJ, Jove R and Koenderman L. (1999). Blood, 94, 1108-1112.
9. Deininger WM, Goldman JM and Melo JV. (2000). Blood, 96, 3343-3356.
10. Digicaylioglu M and Lipton SA. (2001). Nature, 412, 641-647.
11. Dijkers PF, van Dijk TB, de Groot RP, Raaijmakers JAM, Lammers JWJ, Koenderman L and Coffer PJ. (1999). Oncogene, 18, 3334-3342.
12. Flinn EM, Busch CMC and Wright APH. (1998). Mol. Cell. Biol., 18, 5961-5969.
13. Gesbert F and Griffin JD. (2000). Blood, 96, 2269-2276.
14. Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias KE, Schwartz AL, Kahana C and Ciechanover A. (1998). Proc. Natl. Acad. Sci. USA, 95, 8058-8063.
15. Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt Sa, McCredie KB, Campbell ML and Arlinghaus RB. (1993). Hematol. Pathol., 7, 91-106.
16. Hann SR and Eisenman RN. (1984). Mol. Cell. Biol., 4, 2486-2497.
17. Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F and Fernandez-Luna JL. (2000). J. Exp. Med., 191, 977-984.
18. Ilaria RL and Van Etten RA. (1996). J. Biol. Chem., 271, 31704-31710.
19. Jones TR and Cole MD. (1987). Mol. Cell. Biol., 7, 4513-4521.
20. Luscher B and Eisenman R. (1990). Genes Dev., 4, 2025-2035.
21. La Rosa FA, Pierce JW and Sonenshein GE. (1994). Mol. Cell. Biol., 14, 1039-1044.
22. Miyamoto N, Sugita K, Goi K, Inukai T, Lijima K, Tezuka T, Kojika S, Nakamura M, Kagami K and Nakazawa S. (2001). Leukemia, 15, 1758-1768.
23. Mui AL, Wakao H, Kinoshita T, Kitamura T and Miyajima A. (1996). EMBO J., 15, 2425-2433.
24. Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B and Skorski T. (1999). J. Exp. Med., 189, 1229-1242.
25. Okuda K, d'Andrea RA, Van Etten RA and Griffin JD. (1998). Blood, 92, 3848-3856.
26. Ramsay G, Stanton L, Schwab M, Littlewood T and Even G. (1986). Mol. Cell. Biol., 6, 4450-4457.
27. Reuther JY, Reuther GW, Cortez D, Pendergast AM and Baldwin Jr AS. (1998). Genes Dev., 12, 968-981.
28. Rui L and Carter-Su C. (1999). Proc. Natl. Acad. Sci. USA, 96, 7172-7177.
29. Rui I, Gunter DR, Herrington J and Carter-Su C. (2000). Mol. Cell. Biol., 20, 3168-3177.
30. Salghetti SE, Kim SY and Tansey WP. (1999). EMBO J., 18, 717-726.
31. Sambrook J, Fritch EF and Maniatias T. (1989). Molecular Cloning. 2nd Edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
32. Sawyers CL, Callahan W and Witte ON. (1992). Cell, 70, 901-910.
33. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K and Nevins JR. (2000). Genes Dev., 14, 2501-2514.
34. Sherr CL. (1998). Genes Dev., 12, 3499-3511.
35. Shui K, Halpern J, ten Hoeve J, Rao X and Sawyers CL. (1996). Oncogene, 13, 247-254.
36. Sillaber C, Gesbert F, Frank DA, Sattler M and Griffin JD. (2000). Blood, 95, 2118-2125.
37. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B. (1997). EMBO J., 16, 6151-6161.
38. Socolovsky M, Fallon AEJ, Wang S, Brugnara C and Lodish HF. (1999). Cell, 98, 181-191.
39. Stewart MG, Litz-Jackson S, Burgess GS, Williamson EA, Leiboitz DS and Bosswell HS. (1995). Leukemia, 9, 1499-1507.
40. Takeshita T, Arita T, Higuchi M, Asao H, Endo K, Kuroda H, Tanaka N, Murata K, Ishii N and Sugamura K. (1997). Immunity, 6, 449-457.
41. Watanabe S, Itoh T and Arai K. (1996). J. Biol. Chem., 271, 12681-12686.
42. Wilson-Rawls J, Xie S, Liu J, Laneuville P and Arlinghaus RB. (1996). Cancer Res., 56, 3426-3430.
43. Xie S, Wang Y, Liu J, Sun T and Arlinghaus R. (2001). Oncogene, 20, 6188-6195.
44. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitsky A, Kraker A, Krolewski JJ, Medveczky P and Jove R. (2000). J. Biol. Chem., 275, 24935-24944.